COVID-19住院患者早期经验性抗生素使用:一项回顾性队列研究
该研究利用美国N3C数据库66个医疗系统的322,867例COVID-19首次住院患者,定义入院前5天内至少3个日历天静脉抗生素为早期经验性抗生素使用(EEAU),其中43,089例接受EEAU。EEAU从2020年3月的23%降至2022年6月的9.6%,中心间变异显著(偏差解释7.33% vs 20.0%,p<0.001)。第2天前机械通气(OR 3.57)、第2天前ECMO(OR 2.14)和早期升压药使用(OR 1.85)与EEAU相关。倾向匹配后,EEAU与院内死亡风险升高(OR 1.27)、机械通气延长(OR 1.65)、后期广谱抗生素暴露(OR 3.24)和后期艰难梭菌感染(OR 1.60)相关。作者结论为假设生成性,未来应前瞻性比较结局与不良事件。
要点
- EEAU定义:入院前5天内至少3个日历天静脉抗生素;322,867例中43,089例接受EEAU。
- EEAU使用率从2020年3月的23%降至2022年6月的9.6%,但中心间差异显著(偏差解释7.33% vs 20.0%,p<0.001)。
- 第2天前机械通气(OR 3.57;95%CI 3.42-3.72)、第2天前ECMO(OR 2.14;95%CI 1.75-2.61)、早期升压药使用(OR 1.85;95%CI 1.78-1.93)与EEAU相关。
- 倾向匹配后EEAU与院内死亡风险升高相关(OR 1.27;95%CI 1.23-1.33),并与机械通气延长(OR 1.65;95%CI 1.50-1.82)、后期广谱抗生素暴露(OR 3.24;95%CI 2.99-3.52)、后期艰难梭菌感染(OR 1.60;95%CI 1.37-1.87)相关。
- 作者认为研究结果为假设生成性,未来应前瞻性比较结局与不良事件。
适用人群与场景
- 美国N3C数据库中66个医疗系统收治的COVID-19住院患者;数据集住院例数少于500例的中心被排除。
- EEAU定义:入院前5天内接受至少3个日历天静脉抗生素。
诊断标准与关键阈值
- 早期经验性抗生素使用(EEAU):入院前5天内至少3个日历天静脉抗生素。
研究设计与关键结果
- 研究设计:回顾性倾向匹配队列研究,使用美国N3C数据库,纳入66个医疗系统,排除数据集住院例数少于500例的中心。
- 共322,867例符合条件的首次住院,其中43,089例接受EEAU。
- EEAU使用率从2020年3月的23%降至2022年6月的9.6%。
- 中心间EEAU平均率差异显著(偏差解释7.33% vs 20.0%,p<0.001)。
- 第2天前机械通气(OR 3.57;95%CI 3.42-3.72)、第2天前ECMO(OR 2.14;95%CI 1.75-2.61)、早期升压药使用(OR 1.85;95%CI 1.78-1.93)与EEAU相关;居住地区与EEAU无关。
- 倾向匹配后,EEAU与院内死亡风险升高(OR 1.27;95%CI 1.23-1.33)、机械通气延长(OR 1.65;95%CI 1.50-1.82)、后期广谱抗生素暴露(OR 3.24;95%CI 2.99-3.52)、后期艰难梭菌感染(OR 1.60;95%CI 1.37-1.87)相关。
证据类型、等级与局限
- 证据类型:回顾性倾向匹配队列研究。
- 局限:作者自述研究结果为假设生成性(hypothesis-generating),未来应前瞻性比较结局与不良事件。
对床旁实践的改变
- 作者认为研究结果为假设生成性,未来应前瞻性比较结局与不良事件;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate temporal trends and outcomes associated with early antibiotic prescribing in patients hospitalized with COVID-19.
DESIGN: Retrospective propensity-matched cohort study using the National COVID Cohort Collaborative (N3C) database.
SETTING: Sixty-six health systems throughout the United States that were contributing to the N3C database. Centers that had fewer than 500 admissions in their dataset were excluded.
PATIENTS: Patients hospitalized with COVID-19 were included. Patients were defined to have early antibiotic use if they received at least 3 calendar days of intravenous antibiotics within the first 5 days of admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 322,867 qualifying first hospitalizations, 43,089 patients received early empiric antibiotics. Antibiotic use declined across all centers in the data collection period, from March 2020 (23%) to June 2022 (9.6%). Average rates of early empiric antibiotic use (EEAU) also varied significantly between centers (deviance explained 7.33% vs 20.0%, p < 0.001). Antibiotic use decreased slightly by day 2 of hospitalization and was significantly reduced by day 5. Mechanical ventilation before day 2 (odds ratio [OR] 3.57; 95% CI, 3.42-3.72), extracorporeal membrane oxygenation before day 2 (OR 2.14; 95% CI, 1.75-2.61), and early vasopressor use (OR 1.85; 95% CI, 1.78-1.93) but not region of residence was associated with EEAU. After propensity matching, EEAU was associated with an increased risk for in-hospital mortality (OR 1.27; 95% CI, 1.23-1.33), prolonged mechanical ventilation (OR 1.65; 95% CI, 1.50-1.82), late broad-spectrum antibiotic exposure (OR 3.24; 95% CI, 2.99-3.52), and late Clostridium difficile infection (OR 1.60; 95% CI, 1.37-1.87).
CONCLUSIONS: Although treatment of COVID-19 patients with empiric antibiotics has declined during the pandemic, the frequency of use remains high. There is significant inter-center variation in antibiotic prescribing practices and evidence of potential harm. Our findings are hypothesis-generating and future work should prospectively compare outcomes and adverse events.
参考来源
- Widere JC, Davis CL, Loomba JJ, et al. Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19: A Retrospective Cohort Study. Crit Care Med. 2023. PMID: 37125800. doi:10.1097/CCM.0000000000005901
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。